ScoreWhy is Beihai Gofar Chuanshan Biological Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.02%
- The company has been able to generate a Return on Capital Employed (avg) of 1.02% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 1.93% and Operating profit at -237.88% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1.01% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 1.93% and Operating profit at -237.88% over the last 5 years
4
Negative results in Jun 26
- NET PROFIT(HY) At CNY -11.28 MM has Grown at -94.55%
- INTEREST(HY) At CNY 1.31 MM has Grown at 20.81%
- OPERATING CASH FLOW(Y) Lowest at CNY -20.43 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -12.50%, its profits have risen by 53.1%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beihai Gofar Chuanshan Biological Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beihai Gofar Chuanshan Biological Co., Ltd.
-11.88%
0.46
39.59%
China Shanghai Composite
3.0%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.93%
EBIT Growth (5y)
-237.88%
EBIT to Interest (avg)
-19.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.42
Tax Ratio
2.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.82%
ROE (avg)
1.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.53
EV to EBIT
-87.95
EV to EBITDA
-137.62
EV to Capital Employed
5.10
EV to Sales
8.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.80%
ROE (Latest)
-5.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET PROFIT(Q)
At CNY -3.75 MM has Grown at 58.25%
-13What is not working for the Company
NET PROFIT(HY)
At CNY -11.28 MM has Grown at -94.55%
INTEREST(HY)
At CNY 1.31 MM has Grown at 20.81%
OPERATING CASH FLOW(Y)
Lowest at CNY -20.43 MM
ROCE(HY)
Lowest at -12.88%
DEBT-EQUITY RATIO
(HY)
Highest at -9.22 %
Here's what is working for Beihai Gofar Chuanshan Biological Co., Ltd.
Net Profit
At CNY -3.75 MM has Grown at 58.25%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Here's what is not working for Beihai Gofar Chuanshan Biological Co., Ltd.
Interest
At CNY 1.31 MM has Grown at 20.81%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Cash Flow
Lowest at CNY -20.43 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -9.22 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
